7QCY

Two-state liquid NMR Structure of a PDZ2 Domain from hPTP1E, complexed with RA-GEF2 peptide

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D 1H-13C NOESY	2 mM [U-100% 13C; U-100% 15N] PDZ2 domain, 2 mM RA-GEF2 peptide	95% H2O/5% D2O	150 mM	6.8	1 atm	298	Bruker AVANCE 700
2	3D HNCA	2 mM [U-100% 13C; U-100% 15N] PDZ2 domain, 2 mM RA-GEF2 peptide	95% H2O/5% D2O	150 mM	6.8	1 atm	298	Bruker AVANCE 700
3	3D HN(CO)CA	2 mM [U-100% 13C; U-100% 15N] PDZ2 domain, 2 mM RA-GEF2 peptide	95% H2O/5% D2O	150 mM	6.8	1 atm	298	Bruker AVANCE 700
4	3D HNCACB	2 mM [U-100% 13C; U-100% 15N] PDZ2 domain, 2 mM RA-GEF2 peptide	95% H2O/5% D2O	150 mM	6.8	1 atm	298	Bruker AVANCE 700
5	3D HN(COCA)CB	2 mM [U-100% 13C; U-100% 15N] PDZ2 domain, 2 mM RA-GEF2 peptide	95% H2O/5% D2O	150 mM	6.8	1 atm	298	Bruker AVANCE 700
6	2D 1H-13C HSQC	2 mM [U-100% 13C; U-100% 15N] PDZ2 domain, 2 mM RA-GEF2 peptide	95% H2O/5% D2O	150 mM	6.8	1 atm	298	Bruker AVANCE 700
7	2D 1H-15N HSQC	2 mM [U-100% 13C; U-100% 15N] PDZ2 domain, 2 mM RA-GEF2 peptide	95% H2O/5% D2O	150 mM	6.8	1 atm	298	Bruker AVANCE 700
8	3D HCCH-TOCSY	2 mM [U-100% 13C; U-100% 15N] PDZ2 domain, 2 mM RA-GEF2 peptide	95% H2O/5% D2O	150 mM	6.8	1 atm	298	Bruker AVANCE 700

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	700

NMR Refinement
Method	Details	Software
simulated annealing		CYANA

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	2000
Conformers Submitted Total Number	40
Representative Model	1 (target function)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich
3	chemical shift assignment	XEASY		Bartels et al.
4	peak picking	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.